Rupal S. Bhatt, MD, PhD, discusses the potential identification of a pathway of resistance for PD-L1 in renal cell carcinoma.
Rupal S. Bhatt, MD, PhD
Advertisement
Articles by Rupal S. Bhatt, MD, PhD
Rupal S. Bhatt, MD, PhD, discusses the discovery of HHLA2/KIR3DL3, a novel therapeutic immune checkpoint pathway in renal cell carcinoma.
Advertisement
Latest Updated Articles
Dr. Bhatt on Identification of Immune Checkpoint Pathway in RCCOctober 2nd 2019
Dr. Bhatt on Finding a PD-L1 Pathway of Resistance in RCCOctober 25th 2019
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
From Toilet Cleaner to Thoracic Oncologist and Patient: How Ross Camidge Built a Life Worth Loving
3
Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026
4
The OncFive: Top Oncology Articles for the Week of 5/31
5